Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Mesa Laboratories stock | $267.73

Own Mesa Laboratories stock in just a few minutes.

Fact checked

Mesa Laboratories, Inc is a scientific & technical instruments business based in the US. Mesa Laboratories shares (MLAB) are listed on the NASDAQ and all prices are listed in US Dollars. Mesa Laboratories employs 460 staff and has a trailing 12-month revenue of around USD$127.7 million.

How to buy shares in Mesa Laboratories

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Mesa Laboratories. Find the stock by name or ticker symbol: MLAB. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Mesa Laboratories reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$267.73, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Mesa Laboratories, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Mesa Laboratories. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Mesa Laboratories share price

Use our graph to track the performance of MLAB stocks over time.

Mesa Laboratories shares at a glance

Information last updated 2020-12-09.
Latest market closeUSD$267.73
52-week rangeUSD$181.5599 - USD$292.0173
50-day moving average USD$272.5411
200-day moving average USD$249.1805
Wall St. target priceUSD$281.5
PE ratio 736.3871
Dividend yield USD$0.64 (0.24%)
Earnings per share (TTM) USD$0.31

Buy Mesa Laboratories shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Forex
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, ETFs
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Bonds
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Mesa Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Mesa Laboratories price performance over time

Historical closes compared with the close of $267.73 from 2020-12-09

1 week (2021-01-12) -9.79%
1 month (2020-12-22) -6.22%
3 months (2020-10-20) -2.68%
6 months (2020-07-20) 17.43%
1 year (2020-01-18) N/A
2 years (2019-01-18) 23.92%
3 years (2018-01-19) 100.94%
5 years (2016-01-20) 199.68%

Is Mesa Laboratories under- or over-valued?

Valuing Mesa Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mesa Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Mesa Laboratories's P/E ratio

Mesa Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 736x. In other words, Mesa Laboratories shares trade at around 736x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Mesa Laboratories's EBITDA

Mesa Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$32.1 million.

The EBITDA is a measure of a Mesa Laboratories's overall financial performance and is widely used to measure a its profitability.

Mesa Laboratories financials

Revenue TTM USD$127.7 million
Operating margin TTM 11.9%
Gross profit TTM USD$73.4 million
Return on assets TTM 1.94%
Return on equity TTM -0.83%
Profit margin -2.03%
Book value $76.681
Market capitalisation USD$1.4 billion

TTM: trailing 12 months

Shorting Mesa Laboratories shares

There are currently 347,410 Mesa Laboratories shares held short by investors – that's known as Mesa Laboratories's "short interest". This figure is 0.6% up from 345,188 last month.

There are a few different ways that this level of interest in shorting Mesa Laboratories shares can be evaluated.

Mesa Laboratories's "short interest ratio" (SIR)

Mesa Laboratories's "short interest ratio" (SIR) is the quantity of Mesa Laboratories shares currently shorted divided by the average quantity of Mesa Laboratories shares traded daily (recently around 23844.200411805). Mesa Laboratories's SIR currently stands at 14.57. In other words for every 100,000 Mesa Laboratories shares traded daily on the market, roughly 14570 shares are currently held short.

However Mesa Laboratories's short interest can also be evaluated against the total number of Mesa Laboratories shares, or, against the total number of tradable Mesa Laboratories shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Mesa Laboratories's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Mesa Laboratories shares in existence, roughly 70 shares are currently held short) or 0.0848% of the tradable shares (for every 100,000 tradable Mesa Laboratories shares, roughly 85 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Mesa Laboratories.

Find out more about how you can short Mesa Laboratories stock.

Mesa Laboratories share dividends

We're not expecting Mesa Laboratories to pay a dividend over the next 12 months.

Mesa Laboratories share price volatility

Over the last 12 months, Mesa Laboratories's shares have ranged in value from as little as $181.5599 up to $292.0173. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mesa Laboratories's is 0.4105. This would suggest that Mesa Laboratories's shares are less volatile than average (for this exchange).

Mesa Laboratories overview

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Canada, Europe, and Japan. The company's Sterilization and Disinfection Control segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and offers testing services. This segment also provides chemical and cleaning indicators that are used to assess the effectiveness of sterilization and cleaning processes. Its Instruments segment offers data loggers used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air sampling; and torque testing systems used for measure bottle cap tightness. This segment's products are used in healthcare, pharmaceutical, medical device, food and beverage, industrial hygiene, and environmental air sampling industries. The company's Biopharmaceutical Development segment develops, manufactures, and commercializes automated solutions for protein analysis, which include analysis equipment, CDs, kits, and buffers; and peptide synthesizers to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. Its Continuous Monitoring segment offers systems, which are used to monitor temperature, humidity, and differential pressure for use in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was founded in 1982 and is headquartered in Lakewood, Colorado.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site